Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes-MedSci.cn

Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes

Ray, KK; Nicholls, SJ; Buhr, KA; Ginsberg, HN; Kalantar-Zadeh, K; Johansson, JO; Kulikowski, E; Toth, PP; Wong, N; Sweeney, M; Schwartz, GG

EUROPEAN HEART JOURNAL, 2020; 41 (): 1425

科室
- - 订阅+
  - 更多科室
工具
服务